NCT00940888

Brief Summary

The purpose of this study is to characterize the chronic performance of the St. Jude Medical SJ4 connector and RV high voltage SJ4 leads.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,701

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 14, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 16, 2009

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

August 14, 2017

Completed
Last Updated

February 4, 2019

Status Verified

January 1, 2019

Enrollment Period

6.3 years

First QC Date

July 14, 2009

Results QC Date

January 12, 2017

Last Update Submit

January 31, 2019

Conditions

Keywords

ICDCRTDHeart FailureDF4

Outcome Measures

Primary Outcomes (2)

  • Right Ventricle (RV) Bipolar Capture Thresholds

    5 years

  • Complication Free Survival Rate Related to the High Voltage RV SJ4 Lead or SJ4 Connector

    5 years

Study Arms (1)

No treatment: ICD/CRTD-indicated

Device: SJ4 connector and RV high voltage SJ4 lead

Interventions

Standard of care implantation of SJ4 device system

No treatment: ICD/CRTD-indicated

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

ICD and CRTD indicated patients

You may qualify if:

  • Have an approved indication per ACC/AHA/HRS guidelines for implantation of heart failure or life-threatening ventricular tachyarrhythmias and will be implanted with a St. Jude Medical SJ4 system.
  • Have the ability to provide informed consent for study participating and be willing and able to comply with the prescribed follow-up test and schedule of evaluations.

You may not qualify if:

  • Be currently participating in a clinical investigation that includes an active treatment arm.
  • Have a life expectancy of less than 6 months due to any condition.
  • Be less than 18 years of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States

Location

MeSH Terms

Conditions

TachycardiaDeath, Sudden, CardiacHeart Failure

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and SymptomsHeart ArrestDeath, SuddenDeath

Results Point of Contact

Title
Grant Kim, Director Clinical Studies
Organization
Saint Jude Medical

Study Officials

  • Bruce Wilkoff, MD

    The Clevleland Clinic Foundation

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2009

First Posted

July 16, 2009

Study Start

June 1, 2009

Primary Completion

September 1, 2015

Study Completion

December 1, 2015

Last Updated

February 4, 2019

Results First Posted

August 14, 2017

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations